Treatment of melanoma cells with 5 nM everolimus resulted in the decrease of the level of phosphorylated mTOR protein (Ser2448)—associated with the complex mTORC1—by 80% in the case of the Lu1205 line, and by 60% in the WM793 line (Fig. 2a). Here, MTOR is linked to melanoma.